The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-05-27
DOI
10.1093/infdis/jiaa296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cost-effectiveness of HIV pre-exposure prophylaxis among heterosexual men in South Africa
- (2020) Michelle Vogelzang et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
- (2019) Khatija Ahmed et al. LANCET
- HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
- (2019) Connie L Celum et al. Journal of the International AIDS Society
- Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
- (2019) Lara Esteves Coelho et al. Lancet HIV
- Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076)
- (2019) Elizabeth E Tolley et al. Journal of the International AIDS Society
- What impact could DMPA use have had in South Africa and how might its continued use affect the future of the HIV epidemic?
- (2019) Leo Beacroft et al. Journal of the International AIDS Society
- The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
- (2018) Ariane van der Straten et al. Journal of the International AIDS Society
- A systematic review of adherence to oral pre-exposure prophylaxis for HIV – how can we improve uptake and adherence?
- (2018) David Sidebottom et al. BMC INFECTIOUS DISEASES
- Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
- (2018) Raphael J. Landovitz et al. PLOS MEDICINE
- Predictors of HIV, HIV Risk Perception, and HIV Worry among Adolescent Girls and Young Women in Lilongwe, Malawi
- (2017) Joan T Price et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
- (2016) Virginia A. Fonner et al. AIDS
- Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa
- (2016) Robert L. Glaubius et al. CLINICAL INFECTIOUS DISEASES
- Brief Report
- (2016) Brett Hanscom et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women
- (2016) Annalene Nel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- The promise and pitfalls of long-acting injectable agents for HIV prevention
- (2016) Raphael J. Landovitz et al. Current Opinion in HIV and AIDS
- Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study
- (2016) Jennifer A Smith et al. Lancet HIV
- Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
- (2015) Rochelle P. Walensky et al. JOURNAL OF INFECTIOUS DISEASES
- Adolescent girls and young women: key populations for HIV epidemic control
- (2015) Rachael C Dellar et al. Journal of the International AIDS Society
- HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
- (2014) Susan P Buchbinder et al. LANCET INFECTIOUS DISEASES
- Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor
- (2013) W. Spreen et al. HIV CLINICAL TRIALS
- The new role of antiretrovirals in combination HIV prevention
- (2012) Ide Cremin et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation